Europe Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile based Applications, Sensors, and Other Type), By Clinical Practice, By End Use, By Country and Growth Forecast, 2024 - 2031

The Europe Psychiatric Digital Biomarkers Market would witness market growth of 23.8% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Psychiatric Digital Biomarkers Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $147.3 million by 2031. The UK market is registering a CAGR of 22.7% during (2024 - 2031). Additionally, The France market would witness a CAGR of 24.8% during (2024 - 2031).

A convergence of factors fuels the demand for psychiatric digital biomarkers. One of the most significant factors is the increasing prevalence of mental health disorders. Traditional diagnostic methods often fail to detect mental conditions early, underscoring the critical need for scalable, non-invasive, and objective tools like digital biomarkers. The technological advancements driving the psychiatric digital biomarkers market are profound and multifaceted. Smartwatches and fitness monitors are such examples of wearable devices that can collect physiological data, including heart rate, sleep quality, and activity levels. When analyzed through advanced algorithms, these metrics provide valuable insights into a person’s mental health.

Artificial intelligence and machine learning are transforming the analysis of psychiatric digital biomarkers by uncovering patterns and correlations in vast datasets that may not be apparent to human clinicians. Speech patterns and facial expressions are particularly effective in detecting early symptoms of mental health issues, such as mood disorders and psychosis, through the analysis of these technologies. For instance, AI tools can identify subtle changes in voice tone or speech rhythm, which might indicate depression or anxiety, while facial expression analysis can detect micro-expressions suggesting emotional disturbances. One such example is Woebot, a mental health assistant enabled by AI that employs natural language processing to analyze user inputs and offer highly personalized recommendations. These capabilities allow for early detection and intervention, significantly improving patient outcomes.

Suicide remains a critical concern in Europe, particularly among young people. It is the second leading cause of death for individuals aged 10 to 19, with boys dying by suicide at more than twice the rate of girls. UNICEF’s 2021 report, The State of the World's Children: On My Mind, reveals that three adolescents in Europe lose their lives daily to mental health challenges. Anxiety and depression comprise more than half of the mental disorders that affect nearly one in five European boys and over 16% of girls aged 15 to 19. In total, nine million adolescents in Europe aged 10 to 19 are affected by mental disorders. These alarming statistics highlight the critical role psychiatric digital biomarkers can play in enabling early detection, monitoring, and intervention for mental health disorders. Hence, as awareness grows and healthcare systems increasingly recognize the importance of precision tools, the adoption of psychiatric digital biomarkers in Europe is set to rise significantly, presenting lucrative opportunities for market growth.

Free Valuable Insights: The Global Psychiatric Digital Biomarkers Market will Hit USD 2.78 Billion by 2031, at a CAGR of 24.1%

Based on Type, the market is segmented into Wearable, Mobile based Applications, Sensors, and Other Type. Based on Clinical Practice, the market is segmented into Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive and Prognostic Psychiatric Digital Biomarkers, and Other Clinical Practice. Based on End Use, the market is segmented into Healthcare Companies, Healthcare Providers, Payers, and Other End Use. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• Canary Speech, Inc
• Sonde Health, Inc. (Puretech Health Plc)
• Koneksa Health Inc.
• Empatica Inc.
• VivoSense, Inc.
• IXICO Plc
• Neurotrack Technologies, Inc.
• Winterlight Labs
• Aural Analytics, Inc. (Linus Health)

Europe Psychiatric Digital Biomarkers Market Report Segmentation

By Type

• Wearable
• Mobile based Applications
• Sensors
• Other Type

By Clinical Practice

• Diagnostic Psychiatric Digital Biomarkers
• Monitoring Psychiatric Digital Biomarkers
• Predictive and Prognostic Psychiatric Digital Biomarkers
• Other Clinical Practice

By End Use

• Healthcare Companies
• Healthcare Providers
• Payers
• Other End Use

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Psychiatric Digital Biomarkers Market, by Type
1.4.2 Europe Psychiatric Digital Biomarkers Market, by Clinical Practice
1.4.3 Europe Psychiatric Digital Biomarkers Market, by End Use
1.4.4 Europe Psychiatric Digital Biomarkers Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Europe Psychiatric Digital Biomarkers Market by Type
4.1 Europe Wearable Market by Country
4.2 Europe Mobile based Applications Market by Country
4.3 Europe Sensors Market by Country
4.4 Europe Other Type Market by Country

Chapter 5. Europe Psychiatric Digital Biomarkers Market by Clinical Practice
5.1 Europe Diagnostic Psychiatric Digital Biomarkers Market by Country
5.2 Europe Monitoring Psychiatric Digital Biomarkers Market by Country
5.3 Europe Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country
5.4 Europe Other Clinical Practice Market by Country

Chapter 6. Europe Psychiatric Digital Biomarkers Market by End Use
6.1 Europe Healthcare Companies Market by Country
6.2 Europe Healthcare Providers Market by Country
6.3 Europe Payers Market by Country
6.4 Europe Other End Use Market by Country

Chapter 7. Europe Psychiatric Digital Biomarkers Market by Country
7.1 Germany Psychiatric Digital Biomarkers Market
7.1.1 Germany Psychiatric Digital Biomarkers Market by Type
7.1.2 Germany Psychiatric Digital Biomarkers Market by Clinical Practice
7.1.3 Germany Psychiatric Digital Biomarkers Market by End Use
7.2 UK Psychiatric Digital Biomarkers Market
7.2.1 UK Psychiatric Digital Biomarkers Market by Type
7.2.2 UK Psychiatric Digital Biomarkers Market by Clinical Practice
7.2.3 UK Psychiatric Digital Biomarkers Market by End Use
7.3 France Psychiatric Digital Biomarkers Market
7.3.1 France Psychiatric Digital Biomarkers Market by Type
7.3.2 France Psychiatric Digital Biomarkers Market by Clinical Practice
7.3.3 France Psychiatric Digital Biomarkers Market by End Use
7.4 Russia Psychiatric Digital Biomarkers Market
7.4.1 Russia Psychiatric Digital Biomarkers Market by Type
7.4.2 Russia Psychiatric Digital Biomarkers Market by Clinical Practice
7.4.3 Russia Psychiatric Digital Biomarkers Market by End Use
7.5 Spain Psychiatric Digital Biomarkers Market
7.5.1 Spain Psychiatric Digital Biomarkers Market by Type
7.5.2 Spain Psychiatric Digital Biomarkers Market by Clinical Practice
7.5.3 Spain Psychiatric Digital Biomarkers Market by End Use
7.6 Italy Psychiatric Digital Biomarkers Market
7.6.1 Italy Psychiatric Digital Biomarkers Market by Type
7.6.2 Italy Psychiatric Digital Biomarkers Market by Clinical Practice
7.6.3 Italy Psychiatric Digital Biomarkers Market by End Use
7.7 Rest of Europe Psychiatric Digital Biomarkers Market
7.7.1 Rest of Europe Psychiatric Digital Biomarkers Market by Type
7.7.2 Rest of Europe Psychiatric Digital Biomarkers Market by Clinical Practice
7.7.3 Rest of Europe Psychiatric Digital Biomarkers Market by End Use

Chapter 8. Company Profiles
8.1 Canary Speech, Inc.
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Sonde Health, Inc. (Puretech Health Plc)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.2.4.2 Product Launches and Product Expansions:
8.2.5 SWOT Analysis
8.3 Koneksa Health Inc.
8.3.1 Company Overview
8.4 Empatica Inc.
8.4.1 Company Overview
8.5 VivoSense, Inc.
8.5.1 Company Overview
8.6 IXICO plc
8.6.1 Company Overview
8.7 Neurotrack Technologies, Inc.
8.7.1 Company Overview
8.8 WinterLight Labs
8.8.1 Company Overview
8.9 Aural Analytics, Inc. (Linus Health)
8.9.1 Company Overview

TABLE 1 Europe Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 2 Europe Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 3 Europe Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 4 Europe Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 5 Europe Wearable Market by Country, 2020 - 2023, USD Million
TABLE 6 Europe Wearable Market by Country, 2024 - 2031, USD Million
TABLE 7 Europe Mobile based Applications Market by Country, 2020 - 2023, USD Million
TABLE 8 Europe Mobile based Applications Market by Country, 2024 - 2031, USD Million
TABLE 9 Europe Sensors Market by Country, 2020 - 2023, USD Million
TABLE 10 Europe Sensors Market by Country, 2024 - 2031, USD Million
TABLE 11 Europe Other Type Market by Country, 2020 - 2023, USD Million
TABLE 12 Europe Other Type Market by Country, 2024 - 2031, USD Million
TABLE 13 Europe Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 14 Europe Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 15 Europe Diagnostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 16 Europe Diagnostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 17 Europe Monitoring Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 18 Europe Monitoring Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 19 Europe Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 20 Europe Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 21 Europe Other Clinical Practice Market by Country, 2020 - 2023, USD Million
TABLE 22 Europe Other Clinical Practice Market by Country, 2024 - 2031, USD Million
TABLE 23 Europe Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 24 Europe Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 25 Europe Healthcare Companies Market by Country, 2020 - 2023, USD Million
TABLE 26 Europe Healthcare Companies Market by Country, 2024 - 2031, USD Million
TABLE 27 Europe Healthcare Providers Market by Country, 2020 - 2023, USD Million
TABLE 28 Europe Healthcare Providers Market by Country, 2024 - 2031, USD Million
TABLE 29 Europe Payers Market by Country, 2020 - 2023, USD Million
TABLE 30 Europe Payers Market by Country, 2024 - 2031, USD Million
TABLE 31 Europe Other End Use Market by Country, 2020 - 2023, USD Million
TABLE 32 Europe Other End Use Market by Country, 2024 - 2031, USD Million
TABLE 33 Europe Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 34 Europe Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 35 Germany Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 36 Germany Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 37 Germany Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 38 Germany Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 39 Germany Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 40 Germany Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 41 Germany Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 42 Germany Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 43 UK Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 44 UK Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 45 UK Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 46 UK Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 47 UK Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 48 UK Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 49 UK Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 50 UK Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 51 France Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 52 France Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 53 France Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 54 France Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 55 France Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 56 France Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 57 France Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 58 France Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 59 Russia Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 60 Russia Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 61 Russia Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 62 Russia Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 63 Russia Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 64 Russia Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 65 Russia Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 66 Russia Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 67 Spain Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 68 Spain Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 69 Spain Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 70 Spain Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 71 Spain Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 72 Spain Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 73 Spain Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 74 Spain Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 75 Italy Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 76 Italy Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 77 Italy Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 78 Italy Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 79 Italy Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 80 Italy Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 81 Italy Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 82 Italy Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 83 Rest of Europe Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 84 Rest of Europe Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 85 Rest of Europe Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 86 Rest of Europe Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 87 Rest of Europe Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 88 Rest of Europe Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 89 Rest of Europe Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 90 Rest of Europe Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 91 Key Information – Canary Speech, Inc.
TABLE 92 Key Information – Sonde Health, Inc.
TABLE 93 Key Information – Koneksa Health Inc.
TABLE 94 Key Information – Empatica Inc.
TABLE 95 Key Information – VivoSense, Inc.
TABLE 96 Key Information – IXICO plc
TABLE 97 Key Information – Neurotrack Technologies, Inc.
TABLE 98 Key Information – WinterLight Labs
TABLE 99 Key Information – Aural Analytics, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Psychiatric Digital Biomarkers Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Psychiatric Digital Biomarkers Market
FIG 4 Porter’s Five Forces Analysis – Psychiatric Digital Biomarkers Market
FIG 5 Europe Psychiatric Digital Biomarkers Market share by Type, 2023
FIG 6 Europe Psychiatric Digital Biomarkers Market share by Type, 2031
FIG 7 Europe Psychiatric Digital Biomarkers Market by Type, 2020 - 2031, USD Million
FIG 8 Europe Psychiatric Digital Biomarkers Market share by Clinical Practice, 2023
FIG 9 Europe Psychiatric Digital Biomarkers Market share by Clinical Practice, 2031
FIG 10 Europe Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2031, USD Million
FIG 11 Europe Psychiatric Digital Biomarkers Market share by End Use, 2023
FIG 12 Europe Psychiatric Digital Biomarkers Market share by End Use, 2031
FIG 13 Europe Psychiatric Digital Biomarkers Market by End Use, 2020 - 2031, USD Million
FIG 14 Europe Psychiatric Digital Biomarkers Market share by Country, 2023
FIG 15 Europe Psychiatric Digital Biomarkers Market share by Country, 2031
FIG 16 Europe Psychiatric Digital Biomarkers Market by Country, 2020 - 2031, USD Million
FIG 17 SWOT Analysis: Canary Speech, Inc.
FIG 18 Recent strategies and developments: Sonde Health, Inc.
FIG 19 SWOT Analysis: Sonde Health, Inc.